We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£147.14
Humana - Targeting the DNA Damage Response for Anti-Cancer Therapy
Price data last checked 10 day(s) ago - will refresh soon
We'll watch every seller, every day. One email when your price arrives.
This is the most expensive it has ever been. Walk away.
£147 today · previous high £147 · all-time low £144
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 81 days · 81 data points (no recent data)
Price Distribution
Price distribution over 81 days • 3 price levels
Price Analysis
Most common price: £144 (55 days, 67.9%)
Price range: £144 - £147
Price levels: 3 different prices over 81 days
Description
Key Features
Examines the role of DNA damage response (DDR) in the development of tumors.
Analyzes how proficient DDR contributes to cellular resistance against standard-of-care DNA damaging drugs.
Provides detailed information on the impact of ionizing radiation (IR) on cancer cells.
Covers defects in the ATM mediated signaling pathway and their presence in various cancers.
Discusses how genomic instability and persistent mutations occur during tumorigenesis.
Product Specifications
- Brand
- Humana
- Format
- paperback
- ASIN
- 3030093360
- Domain
- Amazon UK
- Release Date
- 21 December 2018
- Listed Since
- 20 December 2018
Barcode
No barcode data available
Similar Products You Might Like
Targeting the DNA Damage Response for Anti-Cancer Therapy (Cancer Drug Discovery and Development)
Humana
Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response (Cancer Drug Discovery and Development)
Humana
Targeting the DNA Damage Response for Cancer Therapy: 186 (Cancer Treatment and Research, 186)
Springer
Springer - The DNA Damage Response Book for Cancer Research
Springer
Mutant p53 and MDM2 in Cancer: 85 (Subcellular Biochemistry, 85)
Springer
Springer Mutant p53 and MDM2 in Cancer - Subcellular Biochemistry 85
Springer
PARP Inhibitors for Cancer Therapy (Cancer Drug Discovery and Development)
Humana
DNA Damage Recognition
CRC Press
DNA Damage Recognition
CRC Press
Humana DNA Repair in Cancer Therapy - Drug Discovery Book
Humana
Academic Press Epigenetics and DNA Damage - Volume 36
Academic Press
Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy
Springer
Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy
Springer
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
Humana
Cancer Epigenetics for Precision Medicine: Methods and Protocols: 1856 (Methods in Molecular Biology, 1856)
Humana
Humana DNA Damage and Repair - Contemporary Cancer Research
Humana
Mechanisms of DNA Damage and Repair: Implications for Carcinogenesis and Risk Assessment: 38 (Basic Life Sciences, 38)
Springer
Molecular mechanisms and physiology of disease: Implications for Epigenetics and Health
Springer
Carcinogens, DNA Damage And Cancer Risk: Mechanisms Of Chemical Carcinogenesis
Scientific Publishing
Targeted Therapies in Oncology
CRC Press
Targeted Therapies in Oncology
CRC Press
Precision Cancer Therapies, Targeting Oncogenic Drivers and Signaling Pathways in Lymphoid Malignancies: From Concept to Practice: 1 (Precision Cancer Therapies, Volume 1)
Wiley-Blackwell
Tumor Suppressor Genes in Human Cancer (Cancer Drug Discovery and Development)
Humana
Environmental Factors, Genes, and the Development of Human Cancers
Springer